You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

App icon
FreshPublishers
Open in the app
OPEN

Cannabis Europa event heads to London

Cannabis Europa has announced the full programme for its 2026 London edition. Taking place at The Barbican on 26 and 27 May, the event will bring together more than 70 speakers — regulators, investors, clinicians and operators — for two days of main stage debate, expert panels, an expanded exhibition floor and a new VIP experience.

The London 2026 edition arrives at a moment of considerable consequence for the sector. Europe's legal medical cannabis market is projected to surpass €1.5 billion according to Prohibition Partners, regulatory frameworks are maturing, institutional capital is increasing, and consolidation is reshaping the competitive landscape. Cannabis Europa London will be the primary forum where those dynamics are debated, interrogated and acted upon.

Program highlights
Day one opens with a State of Play session on the United Kingdom, asking whether the country can move from caution to action after nearly eight years of limited NHS access to medical cannabis. A panel on UN drug policy and international law follows, examining whether incremental progress under the 1961 Single Convention is sufficient or whether meaningful patient access demands a more ambitious top-down rethink. A dedicated session on workplace and driving law complexities will then examine the gap between legal principle and operational practice for CBMP patients across roadside enforcement and HR policy.

© Cannabis Europa

Day two opens with Europe's telehealth crossroads, examining the regulatory push to restrict online prescribing in Germany and its implications for operators, clinics and patients across the continent. A panel on price compression follows, addressing the divergence between collapsed German bulk prices and EU-GMP premium formats and the margin strategies available to operators navigating a tightening market. A dedicated session on cannabis and the gender health gap — addressing endometriosis, menopause and conditions long under-served by conventional medicine — takes centre stage mid-morning, alongside a closing panel interrogating whether Europe's medical cannabis market is making a definitive shift from flower to pharmaceutical-grade formats.

'Cannabis Europa exists because the industry's most consequential conversations require the right room,' said Stephen Murphy, co-founder of Cannabis Europa. 'The London 2026 programme reflects where the European market genuinely stands — more sophisticated than ever before, consolidating, and demanding rigorous analysis.'

The event brings together a diverse and influential group of confirmed speakers from across politics, business, science, and policy. Among them is Kristine Lütke, a former Member of the German Bundestag, alongside Martin Dickie, co-founder of BrewDog and current CEO of Waterside. The lineup also includes Saphira Galoob, CEO of the US Cannabis Roundtable, and Bryan Lanza, who previously served as Communications Director for Trump's Transition Team. Representing the corporate sector are leaders such as Raj Grover, CEO of High Tide, and Philip Schetter, CEO of Cantourage Group SE, while Tim Henley, Strategy Director at Medbud.wiki, adds a policy and data perspective. Scientific expertise comes from Dr Grace Blest-Hopley, Chief Science Officer at Hystelica. They are joined by senior figures from organizations including Fieldfisher, Saul Ewing LLP, the Transform Drug Policy Foundation, and the Geneva Institute, creating a well-rounded program that spans industry, regulation, research, and advocacy.

The expanded exhibition floor will host leading operators and suppliers including Storz & Bickel, Sanity Group, Curaleaf and Cantourage, with a secondary Greenhouse stage running parallel sessions throughout both days. The 2026 Business of Cannabis Awards will be presented on the main stage on 26 May, recognising the companies, clinicians and advocates driving measurable progress across the industry.

A VIP programme runs across both days, comprising exclusive morning breakfasts, private networking, dedicated meeting rooms and awards reception access.

For more information:
Cannabis Europa
https://cannabis-europa.com/

Publication date:

Related Articles → See More